期刊文献+

国产无明胶冻干水痘减毒活疫苗的安全性和免疫原性 被引量:12

Safety and immunogenicity of domestic gelatin-free freeze-dried live attenuated varicella vaccine
原文传递
导出
摘要 目的观察国产无明胶冻干水痘减毒活疫苗的安全性和免疫原性。方法采用随机、双盲、对照、多中心的方法,在广东省兴宁市、揭东县和梅县选择无水痘病毒暴露史的1~12岁健康儿童1 050名,分别接种国产的无明胶冻干水痘减毒活疫苗(试验组)及GlaxoSmithKline Biologicals S.A.(比利时)生产的冻干水痘减毒活疫苗(对照组),进行为期6周的安全性观察;并对其中531名受试者采集免前和免后6周双份血样,采用膜抗原荧光抗体(Fluorescent antibody to membrane antigen,FAMA)法检测抗体水平,评价冻干水痘减毒活疫苗的免疫原性。结果试验组和对照组全身反应的总发生率分别为6.62%和8.06%,组间差异无统计学意义(P〉0.05);局部反应的总发生率分别为4.35%和9.60%,组间差异有统计学意义(P〈0.01);全身反应中以发热为主,局部反应中以疼痛和瘙痒为主,除瘙痒症状(P〈0.01)外,其他症状组间差异均无统计学意义。试验组和对照组免疫后抗体几何平均滴度(GMT)分别为1:126和1:140,组间差异无统计学意义(P〉0.05);抗体阳转或免疫成功率分别为96.99%和96.98%,组间差异无统计学意义(P〉0.05)。结论与对照疫苗相比,在免疫原性相近的前提下,国产无明胶冻干水痘减毒活疫苗可能会降低过敏反应的发生率,具有更高的安全性。 Objective To observe the safety and immunogenicity of domestic gelatin-free freeze-dried live attenuated varicella vaccine.Methods A random,double-blinded control and multicenter trial was performed in 1 050 healthy children at ages of 1 ~ 12 years,who had no history of exposure to varicella virus and came from Xingning City,Jiedong County and Mei County of Guangdong Province.The children were inoculated with domestic gelatin-free freeze-dried live attenuated varicella vaccine,using imported vaccine as control,and observed for safety for 6 weeks.Serum samples were collected from 531 of the children and determined for antibody levels before and 6 weeks after inoculation with fluorescent antibody to membrane antigen(FAMA),based on which the immunogenicity of domestic vaccine was evaluated.Results The systemic adverse reaction rates in trial and control groups were 6.62% and 8.06% respectively,which showed no significant difference(P 0.05).However,the local adverse reaction rates were 4.35% and 9.60% respectively,which showed significant difference(P 0.01).The symptoms of systemic reactions were mainly fever,while those of local reactions were mainly pain and pruritus.The occurrence rates of the symptoms,except pruritus(P 0.01),showed no significant difference in trial and control groups.The GMTs of antibodies in trial and control groups after inoculation were 1 ∶ 126 and 1 ∶ 140 respectively,which showed no significant difference(P 0.05).The antibody positive conversion / successful immunization rates in trial and control groups were 96.99% and 96.98% respectively,which showed no significant difference(P 0.05).Conclusion The immunogenicity of domestic gelatin-free freeze-dried live attenuated varicella vaccine was comparable to that of imported vaccine,while the anaphylactic reaction rate decreased,indicating a higher safety.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第11期1516-1519,共4页 Chinese Journal of Biologicals
关键词 明胶 水痘疫苗 安全性 免疫原性 Gelatin Varicella vaccine Safety Immunogenicity
  • 相关文献

参考文献12

  • 1Sakaguchi M, Nakayama T, Fujita H, et al. Minimum estimated incidence in Japan of anaphylaxis to live virus vaccines including gelatin [J]. Vaccine, 2000, 19(4-5): 431-436.
  • 2白云骅,杨立清,郭丽姝,陶航,艾星,李丽,屈燕,吴疆,时念民,郑艳微,沈艳杰,陈莹.无明胶冻干水痘减毒活疫苗的安全性和免疫原性[J].中国生物制品学杂志,2011,24(11):1336-1338. 被引量:14
  • 3国家食品药品监督管理局.预防用疫苗临床试验不良反应分级标准指导原则[S].2005.
  • 4Chun BH, Lee YK, Lee BC, et al. Development of a varicella virus vaccine stabilizer containing no animal-derived component [J]. Biotechnol Lett, 2004, 26 (10): 807-812.
  • 5Ozaki T, Nishimura N, Muto T, et al. Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan [J]. Vaccine, 2005, 23 (10): 1205-1208.
  • 6Liska V, Bigert SA, Bennett PS, et al. Evaluation of a recombi- nant human gelatin as a substitute for a hydrolyzed porcine gelatin in a refrigerator-stable Oka / Merck live varicella vaccine [J]. J Immune Based Ther Vaccines, 2007, 5 (1): 4-9.
  • 7Kuno-Sakai H, Kimura M. Removal of gelatin from live vaccine and DTaP-an ultimate solution for vaccine-related gelatin allergy [J]. Biologicals, 2003, 31(4): 245-249.
  • 8Nakayama T, Onoda K. Vaccine adverse events reported in post- marketing study of the Kitasato Institute from 1994 to 2004 [J]. Vaccine, 2007, 25 (3): 570-576.
  • 9疏俊.广东省2006年水痘疫情流行病学分析[J].华南预防医学,2008,24(2):49-50. 被引量:11
  • 10黄芳.2006-2007年深圳市水痘流行病学分析[J].预防医学情报杂志,2009,25(4):264-267. 被引量:12

二级参考文献18

共引文献42

同被引文献161

引证文献12

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部